NuvoResearch.com
Mailing ListMailing ListContactsContactsStock QuoteStock QuoteSite MapSite Map
Home
Company Company
History & Milestones
Executive Team
Subsidiaries
Distribution Partners
Pipeline Pipeline
Transdermal Drug Delivery
Immune Regulation
Technology Technology
MMPE
HTE
Investors Investors
Stock Quote
News Releases
Financial Reports
Webcasts and Presentations
Corporate Governance
Shareholder Information
Info Request
Publications Publications
Transdermal Delivery
Immune Regulation
Technology
Careers Careers

About Nuvo
Nuvo Research Inc. is a publicly traded, Canadian pharmaceutical company headquartered in Mississauga, Ontario with manufacturing facilities located in Varennes, Quebec and Wanzleben, Germany, and a research and development facility in San Diego, California.

Nuvo is focused on developing targeted therapeutic products designed to produce minimal side effects. The Company develops drugs based on two technology platforms: transdermal drug delivery and immune system regulation.

Nuvo markets two products Pennsaid®, a topical non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis and Oxoferin, a topical wound healing agent.

Nuvo's primary focus is obtaining approval to market, and ultimately commercialize Pennsaid® in the U.S. market. Nuvo intends to leverage its transdermal drug delivery capabilities to create a portfolio of transdermal products targeting a variety of indications.


Latest News

June 16, 2009 -- News Release

April 30, 2009 -- News Release

April 23, 2009 -- News Release

April 8, 2009 -- News Release



More

What's New

To view our latest Corporate Presentation, please click here.

 


More